source
- FDA expands TEMPO pilot with new digital health partners Limbic, Cadence and DexcomThe FDA is quietly building a pilot program called TEMPO to test a “try first, evaluate later” approach for digital health devices. The agency has added the behavioral‑health firm Limbic to the ro…
- WuXi Bio sells majority stake in chromatography resin maker Bestchrom; Cabaletta adds new CDMO partnerWuXi Bio announced it will divest its 51.1% equity interest in Bestchrom, a Shanghai-based supplier of chromatography resins. The sale will transfer control to an unnamed third party, marking WuXi…